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Lo.9 Angeles. C&7mia 
while awaiting hem trailsplantaticil, 10% to 20% er pgiens 
with hean tilur6 die suddenly (l-3). Amloduone has been 
shown to reduce the rate of nxum”ce of ventlicldar why- 
cardi (4). and to maintain mxmal sinus rhythm in many 
cnmplieath. Amiodsrone Ins be& au&ted -&III an 
was oodertakn to detmnine the tkqoency of pulmonary 
complications, feasibiliiy of accelerated discher@ and re- 
mols for inotmpic end chmnmmpic suppon after 
kart transplantation in patients receivin6 preopemtive ami- 
odemoe therapy. 
Methods 
Stmly @ieots. All patients refeiving amiodamne and 
undergotog tmorplaotatioo at our institution between Sep- 
tsmber 1986 and Septcmkr 1490 were idemikd. Amio- 
damne was prracribed for sustained ventricular tachycardis 
in I I patients. frequent nonsustained ventricular rachyeardii 
in I6 and atrial tihrillotion in 2. It was not prescribed for 
f&ots with marked impairment of pulmonary function 
(foreed expbalory volume in I mio CtissE of that orediited). 
com&x’omi&i Ii&r function (total bilirubm >i mg/dl x 
tmnsaminax greater th?.n twice normal values) or a history 
of hyperthymidism. 
Tbe preopemtive p&es and early postoperative out- 
cootes were compared with those in a groo:, of potiems 
molckd for age and gender. As the oostoowative pmtocols 
nppmximats time of haorptamation. 
Poetepentlve awe. Respimhvy mancrgcmmr. Akr 
transphntatk. patients were extubated as rwn as they 
of low duses of pmsta&mdin E, were routinely administered 
for the 1st 2 days to maintain reoal pmfosioo. Oral terbuta. 
line was occasionally prescribed at discharge for patients 
with a lower heart rate. 
Hospiro/ discborgc. FWients wn dischsgcd whm they 
were clinically stable cm oral medications and ambuhtory. if 
they had a hean mte 270 beatsJmin io sbus rhythm and tk 
fit biopsy. performed 81 eppmximately 7 days. had II) 
evidence of Ggohlcaot rejection. Patients with modcrate 
rejection on the 6mt biopsy genetally remained io the 
hospital 10 complete a course of imravenow methylpredot- 
somne therapy. 
Comparison of prienr groups. Ecbeeardiogmphy war 
oerformed on all txttieots dwiw heat tmosplant evaluation. 
and ejection fraciion WI cokolatcd by Simpson’s role. The 
presence of coronary ntlery disarce was detetaioed by 
ongiogaphy. Polmonruy function tests were oWned pi-e- 
otxratively in palimu with a hismay suggstive of pulmw 
nary dixaw: 17 pathos in the amiedamne 6mop and 13 
@imt~ in tk eomlUl6WJi.. 
To evahmre paiopaative respintory 9atos. we exam- 
ined the duration of assisted ventil6tiin and tk art&al 
orygeo saiumtion oteasofed by fioger pohe oxinwy before 
dischw6e. Acute respimtcey distress symlm~~ was detioed 
p?smrc trial on 40% inspired oxygeo. Ii wcming 
delayed, individual weaoinll sc.hedoles wets devixd by the 
pulmonary nod catdiothomcic temns. Finger pulse arim 
was performed to assess arterial oxyecn satomticm levels ia 
the intensive care unit and in the ob.wv&u unit before 
disehwe. 
Immunosqapres~ion. All p&o& received metbylpred- 
oisobme. SMt m6 iouaopemtively, Wowed by 125 m.q every 
12 h fa 36 h. Forther immuoosupp~ssioo was initiated 
prine io ali &ois withoil int&no6 i#nm$c sow 
cases pati& with early po&mtivc oli&n received 
azathioprhte sod o 4- to 6day - of OKT3 followed by 
cydosporine @en orally aReI -ry of lOmtol renal 
folMion. However. kcaose of eoocero about poleotial 
pllmooary complicatioos, OKT3 WBI &omUy avoided in 
and I2 cootml patients reeeivedOKT3. _ 
Hemodynomlc sup~~orl. 1~ support for weaning 
tium cmdiopoboooary bypass wee motioely instihoe6 with 
5 & per ti of bah dopmnioe eaul dobommint. H&her 
infection: asessed by the dose 
of iootmpic druga mqoimd to stobilii tk @ent’s co& 
Coo immediately Sner wmdog fmm cmdiopnlmoluay by- 
pass, tbc numba of days ON inonopic tberppy. the dmatica 
of atria1 oncilg sum and tk heart rate at hwimt 
disebarge.~Ov&l mmbidity wea &mated from tk d&z- 
tion of inpmkit stay. Rosily, May mortality * was 
determined for the patits receivin.6 oo&&one. tk sp+ 
eik control parimtr selected and the t’eomioi~ IW pst*ntr 
uodmgc4ng traorplanution at our iostitotioo doriryl tk 
z-year peric!d. 
Student t test cbr combmoos vatiables. All i&an vahxs ore 
expressed with SD. 
Result6 
There were 110 si&icmt diinces between the 29 
patients receivhg amiodarooe therapy nod tk 23 matched 
tmospraot recipicats Iw see. ejaioo Cactioo, freqoeocy Cd 
This sopport was rootin~&taioed for 24 h. thm 
oily aritMnwn as t&mated. 
If addilimml therapy was oeeesealy for cbmnotmpic 
soppot? to maintain o heart rate >75 beats/min. otrial peiep 
was used wheo possible, accompanied in some cues by 
at itdtii cvrdualion was 24 ? 10 mm Hg in the amiodaronc 
#raw versus 23 f 10 mm & in the epnttol BCUD. Averace 
with a uvraticm of II * 22 months. The daily dose was 
20Dmein160fthe29Dstientsandwss~~in6. 
Fuihnary stabs. poslopcrative pulmonary status was 
similar in the two groups. The mean duration of bmtbmion 
was 212 I9 h in patients receiving amiodatune compared 
with 26 d 2 h CD - MI in control mticnts (after excludhm 
one control pat&d &remained i&bated hh P eparate~ 
sternum for 20 days until death). Excluding all 14 patients 
who received 0KT3 because of a petwived higher risk of 
renal failure and muired intubation far 42 + I10 It. mtienls 
receivbt6ami&rot!ewreitttuMedfor20 f I8 hcom+ured 
with IS + 9 h in contml @ear (p = NS). The six p&ins 
with doses MOO mg had intubation for 20 d 16 b. Aaerial 
orygea~ saturation mw.wcd by lin6er pulse oximetry was 
%+2WinlheMliodamnc~oupand97+24binthe~ 
EWJD before discharee. 
Four patients f&each gnwp requhzd >48 h of assisted 
vclltilation. 0KT3 had been ndministered for 5 dws in one of 
these pmiems on amiodamne therapy and in tire in the 
mntml 6m”p. Two patients receivir~9 amiodnmne who had 
not received OKT3 had some &mats of the adult resplra- 
tory distress syndrome PI detined earlier, pltbcu& the 
mlatiwly beni@ ccursc su69ests the severity ofwmpliince 
abnormalities to be less than that tuttally described fm this 
syndrome. One wa8 a 6Byear dd man with a MB pack- 
year smoki~ history who had received amiodarone for 4 
months with B daily maiotenance dose uf 2W mg. Ahho& 
infection was not positively diagnosed during bis tit&ion. 
was reintubatcd for pgressive hypoxemla on his 3rd has- 
pital day cons&tat whh amiodamnblndwed pulmonary 
toxicity. The chest X-ray film shomd blUe.ml intilhata. 
and bmncboawpy showed pulmnary edema. All culbxes 
from bmncbaxopy wshilg were ne.gttive for patb~ns 
after5 days. The &at remained iolttbated for% h and w 
discharged sfter a total hospital stay of II days. Ofthc four 
bwcascd in the amlcdaw &up fl&lc 2). The average 
dobutamine and dopamine doses req&d for sttlbilhrcion 
dttrina wea@ fxxn cardiopllmonnq bytes were sin&a 
totalday~ofintrav&w*inotmpic~Q.l * l.Sdayl 
vs. 3.5 f 2.5 days in the caurd crow. D -z 0.O.V. 
Miifi*nl+tgsupponwrcq&ditt&ttpatimLI 
receMnganmdamne(nKandtumii3*2daya);ittcaR 
trait, Iw comml patients squid pa+_ for I day each 
@ < 0.01). plebt# was required for 3 days In one &be six 
mtimta mwicusl~ receivinn >4Mt ntakkw of amind-. 
P-C &tS). liowva, all patients VICE in sinus rhythm-at tk 
time of dischm except one patient who reqti a perms- 
nent pacemaker for per&teat jusctionrd rhythm witbout 
appvem inus node ftmction. Oral terbwdine wm prp 
scribedf~~ I motttb afterdiwhsrae in two @ents reaeiving 
uniodamne and in no control &ent. 
Hmpltdoutcome. TwopatientsitttberEaegmup 
died within 3l1 days of ttansplatttati~ OC dny morality tate 
of6.896). One @cot diid ofri@ heart failme caplicated 
by pnatmadn and renal failure. and tbc other. rho bad 
r&&d intravemw hrdbxm countaptdeation 4.weeL.p be 
fom tmn+ntatimt. died cd b&one& wumcida. In the 
control group. one patient died witbin 30 days dtrsarpllrp 
tation of a mcdiartinnl wmmd infecdon at Ihe site of a l.01~ mmplicatim rates with mnbdaaw. Fiimor~ary 
previous sternezmmy alter B wmplicnted coronary re- complioalions. manifead by elements of the adult respire- 
vase~lwization pmcedure, for a M-day mortality rate of tory distress syndmme. occwred in 2 of29 patients receiving 
3.4%. Howewr, one other comml pienr died during the amicdarone. However. even these pathznts required assisted 
initial bospkal period 96 days atIer a transplant pmcedure ventilation for only 7 to 3 additional &is. B&h patients had 
that ws com@ated by organ failure and disseminated a >I06 pack-year smoking history, wbiih in itself is ass& 
infc~lim~. The total operative monaliiy raw was 6.6% in bath ated uilh incremd pulmonary mmplica~kms afar cardiac 
groups and not s@dflc.mtly diErent fmm the 3.7% opra- operations (181. Assisted wtiladcm was required for X8 h 
live mortality rate in the other IS0 patients undergaing in only two other palimt9 receiving amiodamne and the 
tfansplaWation in this progmm from 1985 to 1996. There average duralion &his suppnr~ was not longs than that far 
were no deaths afta discbage within the 1st 3 months for the control patients. AU patienls were discbarged with 
either gmoup. normal arltial oxyeen mlwatkm. 
The patients receiving amiodacme did not manifest de- 
pression of cardiac contractility OT vprular tone requiring 
In!xllBion 
incrvascd support with ;lotmpic drugs. The heart mtcs were 
lowr. as is expected lmm the !ang b&life dnmiulanme. 
Rwbusg&dlaan~. Patientswbos~outof which is redistibulcd into the recipient hart (19). How- 
the hospital awaiting bead transplsntfdion are gl risk for ever. thex lower mtes were gaily managed with atrial 
sudden dab. which occurs in lC% to 26% of candidates by wing. which WBP gnenrlly ml m@‘ed afta lhe early 
6 mombs (I-3). a p&ad equivalent to the approximate posIo9eIfllive dayr. The discbarge bean mle was sliiy 
emvent wailing time 6x hanwlantadon. Maw of thssc lower for the amiodamne reci&ms. One wlisnt (4% of 
deaths are rel&d to primary n&thmias or a&hmias in 
the setting of ischcmia. Amiadamne has teen shown to 
reduce the ncunmce of venriculrt~ tacbycafdii (4) and 
atrisllibn~~onQ,botholw~hharcbeenspsoeistednrith 
M increased bxidmse Opsudden death in patients with heart 
Sbwc (12.13). mvi expuimental evi&ncc suggests tint il 
may c&r same proteclia~ from ischmdc arrhythmias as 
well (14). AmiodPrme tbereforecoukl pater.tiaUy reduce the 
matidily rate b&z tmns9lawion. 
Amiodgmne ha been lpnoeirtted with many 6id6 6Rcls. 
paiculwly pulmonmy toxicity, wbicb occurred in 6% d 
puients in cme series (15); the rist g9pcars l@kest when 
dases 2400 ny daily we wed chm&aUy. Older patients 
also appsr to be at biir risk. Small retmspect& studies 
of~~~watmns have implic&d amiadarone in 
yard&n& and vasaliition refractory 
to exo@naur vrro~nslriEtm thaapy (:6). Tb6 pOaopaa 
rivepwiaddter~monaty~~rybyplss~l~~defibril- 
lamr implgnmtion has tea complicated by the adull nspi- 
survivors) did require * perman& paamakei for pm&stat 
jwtimmi dwhm. but lhir rate is kwu Tao that genemlly 
otaerved for prmancnt pwcmukcr mqkmem atter I-W 
cf hospital stay. did not increa~-i. Ihc amiad&wtreaied 
(4. A8 uanaplam tiwd high doses dcaticc- 
stir. which sbadd diminish aclivgtkm af the inflpmmg- 
mry medii tha! may comfnumisc pulmonary !im&n 
faflcrcafdigco~i?lppI*otswilbmt immunosupprcp 
sion. Perhaps & use d dcriclpwtivc immnosupprasion 
add diminish p.damwy inf$mmatory relponae~ after an- 
esthesia. The lack dadvenc bcmcdynamic e&cls is rilniQl 
m Ihe exwience rrponed by MxDmmld et al. (II), rho 
institution’s s&e of 2i days. in current 
swdy. prim amicdarone dse did not lead to longer hospital 
stpys even when an aggmssive policy of early discharge was 
pursued. limiting the aveage hospital slay to 10 days aflcr 
tnnsplamatio,,. 
LMns ol aud:‘. This study is limited by the small 
sire and retrospective design in which not ail variables are 
mprched. patients not nxeiving amiodamne may trve ap 
pared more compmmiscd in subtle ways. so tha, amia- 
damnc therapy was no: considered. There were three more 
palie~s io the mmml goup than in the amiodamne gmup 
undewing urgent transplantation. a dilference that could 
have inclrased the complication mte compand in rbe con- 
hwlgxwp with thatintheamiodaronegmup.Thedsision,o 
and, in general, is Fsvorcd in palients perceived 10 be a, 
hii risk for prioperative renal failure on the bnsis of 
multiple crileria. More contml patieas received OKT3. 
which can itself caw pulmon&j complicatio,Js. If mea 
amiodamne4rea,rd oadenls had received OKT3. it is DOS& ~-r---- 
Me that a synergy between amiodamne and OKT3 might 
have l d to greater compmmise of powperative respiratory 
stahui. Altbcqd, the relative s&y ofamiadanm~ esm~ be 
generalized from this study to patients receiving OKT3 
indue(ion tbempy. ~hcn is increasing evidence that such 
induction therapy wilh 0KT3 may not bc mutillely indicated 
for im~suppression a&r heart transplantation 93). On 
the older Cud, mrlimstemid lhempy may have suppressed 
evidence of postopemtive rniodamne canpli~icm that 
mi&t hdw been more evident if patients had received lowr 
coti~,emid doses. Amiodamne dose and dumtion were 
relatively low in this ~poup. Our resulls should no, be 
generalized to patients receiving prolonged biib doses cd 
gay. patients G patients treated 
tith loara initial cortieostemid doses. 
lm-. As waiting lime for heal transplants(ion 
increases, fbe issue of pmventmg sudden death bcenmer 
incrcasi@y importam. Many antirrlhythmic agents can 
~va,c heart failure because of their ne@ive inampic 
efists (241. Kecenl evidwe has shown that some class I 
antimvhflhmic agents may actually increase the incidence of 
sudden death, particularly in pa&s with porn ventricular 
hwion (25.26). These risks scan to be low with ati 
damne therapy, but pulmonary, neumlcgic and hepatic 
toxicity remain m+ concerns (27.28). Our stud) &ows 
that therapy with amiodarone b&v transplamation may 
wcarionally cause postopemtive rqiratmy mmplicaiions 
but rarely delays hospital discbarge. Althou.& the indica- 
tionr must be carefully wigbed. amiodsmnc may become 
the drug of choice for the therapy of vmtricuhr and atrid 
arrbytbmias in candidates for hewi transplantation at hii 
risk for sudden death. 
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